Have a Histologically or cytologically confirmed non-CNS solid tumor that is metastatic or unresectable and for whom there is no available standard therapy.
Have at least one lesion, not previously irradiated that can be accurately measured per RECIST version 1.1.
Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.
Age of 18 years or older (or country's legal age of majority if the legal age was \>18 years)
Adequate Hematologic and liver function.
You may not be if
Has received prior therapy with an anti-4-1BB(CD137) agent.
Known active CNS metastases and/or carcinomatous meningitis.
Known additional malignancy that is progressing or has required active treatment.
History of chronic liver disease or evidence of hepatic cirrhosis.
History of severe toxicities associated with prior immunotherapy, except for adequately controlled endocrine-related adverse events managed with hormone replacement therapy.
Has ongoing or suspected autoimmune disease.
Known active and clinically significant bacterial, fungal or viral infection including known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness, immunocompromised patients.
